Cervical high risk human papillomavirus (HPV) DNA test positive. R87.810 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM R87.810 became effective on October 1, 2018.
You might need more frequent testing if:
You may need to come back sooner if you had abnormal results in the past. Abnormal Pap test results: An abnormal test result may also be called a positive test result. An abnormal test result does not mean you have cervical cancer. Possible abnormal findings on a Pap test include ASC-US, AGC, LSIL, ASC-H, HSIL, AIS, or cervical cancer. Your health care provider will recommend follow-up steps you need to take based on your specific test result and your past test results.
Z12.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z12.4 became effective on October 1, 2020. This is the American ICD-10-CM version of Z12.4 - other international versions of ICD-10 Z12.4 may differ.
ICD-10 Code for Unspecified abnormal cytological findings in specimens from cervix uteri- R87. 619- Codify by AAPC.
ICD-10 code Z11. 51 for Encounter for screening for human papillomavirus (HPV) is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
R87. 810 - Cervical high risk human papillomavirus (HPV) DNA test positive | ICD-10-CM.
R87. 619 - Unspecified abnormal cytological findings in specimens from cervix uteri | ICD-10-CM.
Z12.4 – Encounter for screening for malignant neoplasm of cervix*
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient.
81 for High risk human papillomavirus (HPV) DNA test positive from female genital organs is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
2022 ICD-10-CM Diagnosis Code N87. 1: Moderate cervical dysplasia.
CPT code 90650 is an FDA-approved HPV vaccine for females only age 9-26. For recipients age 9-18, code 90650 is reimbursed through the VFC program. The three-dose schedule for either code for recipients over age 18 must begin and end before the recipient turns 27.
The appropriate ICD-9-CM code is 233.1 (CIN III/CIS/Severe Dysplasia). The appropriate ICD-10-CM code is D06.
When the provider repeats a Pap smear because of an inadequate sample or abnormal results, you’ll report a code from R87.61- Abnormal cytological findings in specimens from cervix uteri.
There’s an impressive list of Excludes1 and Excludes2 notes at the R87.61- level, meaning the list applies to all codes in that subcategory.
Subcategory R87.61- has a lot of codes, so don’t miss two slightly different ones in the middle:
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
This article gives guidance for billing, coding, and other guidelines in relation to local coverage policy for L34089-Human Papillomavirus (HPV) Testing.
It is the responsibility of the provider to code to the highest level specified in the ICD-10-CM. The correct use of an ICD-10-CM code listed below does not assure coverage of a service. The service must be reasonable and necessary in the specific case and must meet the criteria specified in this determination.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.